Immunotherapy in Kidney Cancer
0 Visningar
• 06/26/23
0
0
Bädda in
administrator
Prenumeranter
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna